Key Drivers
- Strong cash flow
- Thin profitability
- Weak liquidity
AIAI Summary
CAH is now a cash-generative healthcare-services and specialty-growth story rather than a pure distributor, but at ~33x earnings investors should require proof that post-refund, post-tax-item operating growth and free cash flow remain strong as Specialty normalizes and acquisitions integrate.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong cash flow
- •Thin profitability
- •Weak liquidity
CAH delivers strong cash flow and manageable leverage, but thin margins, negative equity, and weak liquidity warrant caution despite a low sales multiple.
Price Behavior
Key Price Behavior Insights:
- •Downtrend intact
- •Support test
- •Rebound threshold
CAH is in a bearish last-month downtrend, with $225–226 support at risk; reclaiming $232–235 would signal easing pressure.
Selling accelerated on 2026-09-17 and 2026-09-18
Sentiment & News
Key News Insights:
- •Growth Momentum
- •Institutional Buying
- •Margin Risks
Cardinal Health's growth drivers and institutional backing support a constructive outlook, though pricing, cost, and capital-spending risks warrant monitoring amid recent share weakness.
Overall, the news is moderately positive for CAH, but near-term volatility may persist as investors weigh execution and cost pressures
Similar Companies in Healthcare
Other companies in the same sector with AI ratings